But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

For COPD, it’s been tricky to pin ... the third received both the new benralizumab injection and the standard steroid pills. After 28 days, symptoms like coughing and breathlessness had ...

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start," with more than 3,500 healthcare ...

“The exciting news is that there is a drug that looks like it will work for COPD, and that may soon have [U.S. Food and Drug ...

Chronic obstructive pulmonary disease (COPD) has seen no new therapies ... representing a massive new opportunity for a drug that is already a huge seller across several indications, including ...

Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio. Headquartered in Switzerland, Windward Bio is a ...

(RTTNews) - British drug maker GSK plc (GSK ... Nucala is currently not indicated for COPD anywhere in the world. For More Such Health News, visit rttnews.com ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

"Unfortunately, no drug gets rid of asthma completely ... "But it’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years," she said.

Medscape Medical News, July 26, 2024 Breathtaking Drug Costs Hamper COPD Care Nearly 20% of US patients with chronic obstructive pulmonary disease skip or delay doses due to high monthly out-of ...